Prevalence and risk factors for albuminuria among type 2 diabetes mellitus patients: A Middle-East perspective

Diabetes Research and Clinical Practice

Volumn 88, Issue 3, 2010, Pages

  Prashanth, P ^a   Sulaiman, K J ^a   Kadaha, G ^b   Bazarjani, N ^b   Bakir, S ^b   Jabri, K El ^b   Sabr, F Al ^b   Mahmoud, H ^b  

^a ROYAL HOSPITAL   (Oman)

^b Dubai Fertility Center   (United Arab Emirates)

Author keywords

Albuminuria; DEMAND study; Gulf countries; Microalbuminuria; Middle East; Type 2 diabetes

Indexed keywords

ADULT; ALBUMINURIA; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MIDDLE EAST; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; ADOLESCENT; AGED; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 78349238590     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.02.004     Document Type: Article

References (11)

1. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
2. Diabetes Atlas, third edition ©International Diabetes Federation. , 2006 (accessed 24.10.08). http://www.eatlas.idf.org/media/.
3. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. DEMAND investigators: prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006, 69:2057-2063.
4. Pan C.Y., Ho L.T., Soegondo S., Prodjosudjadi W., Suwanwalaikorn S., Lim S.C., et al. DEMAND study investigators: prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol. Ther. 2008, 10:397-403.
5. Rossi M.C.E., Nicolucci A., Pellegrini F., Comaschi M., Ceriello A., Cucinotta D., et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND study. Nephrol. Dial. Transplant. 2007, 0:1-7.
6. Al-Futaisi A., Al-Zakwani I., Almahrezi A., Al-Hajri R., Al-Hashmi L., Al-Muniri A., et al. Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: a cross-sectional observational study in Oman. Diabetes Res. Clin. Pract. 2006, 72:212-215.
7. Glans F., Elgzyri T., Shaat N., Lindholm E., Apelqvist J., Groop L. Immigrants from the Middle-East have a different form of Type 2 diabetes compared with Swedish patients. Diabet. Med. 2008, 25:303-307.
8. Alberti K.G., Zimmet P.Z. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet. Med. 1998, 15:539-553.
9. Heerspink H.L., Brantsma A.H., Zeeuw D., Bakker S.L., Jong P.E., Gansevoort R.T. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality: for the PREVEND Study Group. Am. J. Epidemiol. 2008, 168:897-905.
10. Beamer N.B., Coull B.M., Clark W.M., Wynn M. Microalbuminuria in ischemic stroke. Arch. Neurol. 1999, 56:699-702.
11. Ibsen H., Olsen M.H., Wachtell K., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., et al. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care 2006, 29:595-600.